Modulation of astrocyte inducible nitric oxide synthase and cytokine expression by interferon β is associated with induction and inhibition of interferon γ‐activated sequence binding activity
Although interferon (IFN)‐β is firmly established as a therapeutic agent for multiple sclerosis, information regarding its role in astrocyte cytokine production is limited. In primary cultures of human astrocytes, we determined the effects of IFN‐β on astrocyte cytokine [tumor necrosis factor‐alpha...
Saved in:
Published in | Journal of neurochemistry Vol. 83; no. 5; pp. 1120 - 1128 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Oxford, UK
Blackwell Science Ltd
01.12.2002
Blackwell |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Although interferon (IFN)‐β is firmly established as a therapeutic agent for multiple sclerosis, information regarding its role in astrocyte cytokine production is limited. In primary cultures of human astrocytes, we determined the effects of IFN‐β on astrocyte cytokine [tumor necrosis factor‐alpha (TNF‐α) and interleukin (IL)‐6] and inducible nitric oxide synthase (iNOS) expression by ribonuclease protection assay and ELISA. We found that IFN‐β inhibited astrocyte cytokine/iNOS induced by IL‐1 plus IFN‐γ, but in the absence of IFN‐γ, IFN‐β enhanced IL‐1‐induced cytokine/iNOS expression. Electrophoretic mobility shift analysis (EMSA) demonstrated that IFN‐γ induced sustained IFN‐γ‐activated sequence (GAS) binding, while IFN‐β induced transient GAS binding. When used together, IFN‐β inhibited IFN‐γ‐induced GAS binding activity. Nuclear factor‐kappa B (NF‐κB) activation was not altered by either IFNs, whereas IFN stimulated response element (ISRE) was only activated by IFN‐β and not IFN‐γ. These results suggest that IFN‐β can both mimic and antagonize the effect of IFN‐γ by modulating induction of nuclear GAS binding activity. Our results demonstrating differential regulation of astrocyte cytokine/iNOS induction by IFN‐β are novel and have implications for inflammatory diseases of the human CNS. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 |
ISSN: | 0022-3042 1471-4159 |
DOI: | 10.1046/j.1471-4159.2002.01226.x |